← All trials
NCT05550142
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 16, 2022
- Primary completion
- Dec 31, 2022
- Completion date
- Mar 31, 2024
- First posted
- Sep 22, 2022
- Last posted
- Dec 2, 2022
- Enrollment
- 54
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- AIM Therapeutics Inc.Collaborator
- Bengbu Medical CollegeCollaborator
- Bengbu Medical CollegeOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.